Tag: WallabyPhenox
One-month COATING data may represent “first step” towards reducing antiplatelet use...
Primary-endpoint findings and initial safety data from the COATING trial—presented by principal investigator Laurent Pierot (Reims University Hospitals, Reims, France) at the 2025 LINNC...
COATING study results set to have “tremendous impact” on intracranial aneurysm...
This advertorial is sponsored by WallabyPhenox.
Ahead of the COATING study’s much-anticipated final analyses, principal investigator Laurent Pierot (Reims University Hospitals, Reims, France) sits down...
